Thus, inhibiting histamine N-methyltransferase in astrocytes offers the possibility of enhancing histamine’s beneficial effects in AD patients’ brains, such as improving cognitive function, promoting neural plasticity, and facilitating Aβ peptide degradation. Here, HNMT is linked to Alzheimer disease.